Vigeo Therapeutics
PrivateLast Round
Series C
Mar 10, 2021
Total Funding Raised
$62.58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vigeo Therapeutics is a biotechnology company that develops novel therapeutics for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vigeo Therapeutics Comparables
Compare Vigeo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapience Therapeutics | 80% | |
| Bexion Pharmaceuticals | 78% | |
| Imvax | 77% |
Vigeo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 10, 2021 | ||||
| Series B | Dec 19, 2018 | ||||
| Series A | Nov 15, 2017 | ||||
| Series A | Jun 12, 2015 |
Vigeo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A, Series B |
| Morningside Group | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 9, 180% of current headcount.
- Mar 25, 2021
Raised $8 million in debt financing.
Vigeo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vigeo Therapeutics's valuation, stock price, and market status.
Is Vigeo Therapeutics a public or private company?
Vigeo Therapeutics is a private company.
What is the current stock price of Vigeo Therapeutics?
Vigeo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Vigeo Therapeutics worth (valuation)?
Valuation information for Vigeo Therapeutics is not publicly available.
Can I buy Vigeo Therapeutics stock?
Vigeo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vigeo Therapeutics's last funding round?
Vigeo Therapeutics's most recent funding round was Debt on March 25, 2021.
Who are the main investors in Vigeo Therapeutics?
Key investors in Vigeo Therapeutics include Morningside Ventures, Morningside Group.
Will Vigeo Therapeutics IPO soon?
No public IPO plans have been announced for Vigeo Therapeutics.
How can I track Vigeo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vigeo Therapeutics's secondary market activity and sign up for updates.